What Is the Success Rate of BCG Treatment for Bladder Cancer?

Bladder cancer is a relatively common cancer that affects the urinary system. If not treated early, it can spread to other parts of the body and become fatal. 

Bladder cancer is most commonly diagnosed in older adults. It grows slowly and usually does not cause symptoms until it is large and spreads to other organs. 

Bladder cancer treatment options include chemotherapy and radiation therapy. Patients who are diagnosed with this kind of cancer are usually given BCG treatment to help fight cancer. Let’s have a look at the success rate of BCG treatment for bladder cancer. 

What is BCG?

One of the treatments for bladder cancer is Bacille Calmette-Guerin (BCG), which is a vaccine made from weakened Mycobacterium Bovis. This vaccine stimulates the immune system and causes an increase in anti-cancer proteins.

Bladder Cancer and Its Symptoms

Bladder cancer is an invasive type of cancer that develops within the bladder. It affects the cells in the bladder and progresses slowly. When the cancerous cells spread to other parts of the body, it is referred to as metastasized bladder cancer. 

The symptoms of bladder cancer are often vague or non-existent and so it can be hard to detect or diagnose. The symptoms depend on where the cancer is in the bladder i.e., whether it is contained only in the bladder or it has spread to other parts of the body. 

The signs you should look out for include frequent urination, blood in the urine, pressure in your bladder and pain when urinating.

When cancer spreads out of the bladder, it is called metastasis. The most common place for metastasis of bladder cancer is in the bones, lymph nodes, liver and lungs. The symptoms of bladder cancer from its initial stage to the advanced stage include dizziness, difficulty in breathing, rashes, joint pain and in rare cases fever.

When Do Doctors Use BCG?

Doctors most commonly use BCG to treat superficial bladder cancer. The vaccine stimulates the immune system to attack cancer cells in the bladder. It can be used with intravesical chemotherapy for advanced stages of bladder cancer. 

Also Read: TREATING BLADDER CANCER: WHAT PATIENTS NEED TO KNOW

It is not recommended for those who have weakened immune systems. While BCG treatment for bladder cancer can be effective, it is not a cure. It can help prevent cancer from recurring. 

Success Rate

The success rate of BCG treatment for bladder cancer is 100% if it is detected in the early stages. It can be as high as 90% even in the later stages. 

Be sure to take note of the early signs and symptoms of bladder cancer so that you will be able to detect it in its early stages, which greatly increases the treatment rate and the survival rate, especially in the later stages. 

If you notice blood in your urine, be sure to consult your doctor immediately. A large majority of people who have bladder cancer are diagnosed for it while they are still in the early stages. More than 90% of people who are diagnosed with bladder cancer in the early stages survive treatment. 

What to Expect Before BCG Treatment?

Before you are scheduled for BCG therapy, you will have to go through a screening test. This screening will determine whether you are eligible for BCG treatment or not. Factors considered during this screening test include the patient’s age, cancer type and stage, and overall health. 

The doctor along with a radiation therapist will determine the best course of treatment for your condition and also ask you to avoid drinking too much fluid like water, juice, or caffeine. 

If you are eligible, you will be given a date to schedule your treatment and will receive specific instructions on how to prepare. Once BCG is injected into the bladder, you will have to wait for 1-2 hours before urinating. This will allow the medicine to reach all the areas of the bladder. 

Also Read: BLADDER CANCER: FACTS, FIGURES, AND STATISTICS YOU MUST KNOW

The success rate of bladder cancer treatment will vary depending on the age of the patient and the stage of the disease. Bladder cancer is a common and treatable disease, but bladder cancer treatment can be complex and challenging.

 There are different treatment options available, each with different pros and cons. The best treatment option for you will depend on your situation and health. 

We hope the information was helpful for you to understand what BCG treatment is, its symptoms, and what you can expect after the treatment. This method of treatment is considered a form of immunotherapy, which is an emerging form of cancer treatment. 

The success rate for BCG treatment for bladder cancer is about 90%, which is considered the best life-saving rate by any treatment.  

Frequently Asked Questions (FAQs)

What is BCG treatment for bladder cancer?

BCG (Bacillus Calmette-Guérin) is a type of immunotherapy used primarily for certain non-muscle-invasive bladder cancers. It is placed directly into the bladder through a catheter to stimulate the immune system to target abnormal cancer cells.

How does BCG treatment work for bladder cancer?

BCG works by stimulating an immune response inside the bladder. This helps the body’s immune system recognise and attack cancer cells and can reduce the risk of the cancer returning after initial treatment.

What type of bladder cancer is treated with BCG?

BCG is mainly used for non-muscle-invasive bladder cancer, particularly cancers considered at higher risk of recurrence or progression. The suitability of BCG depends on factors such as tumour characteristics, grade, stage and the patient’s overall health.

How is BCG treatment given for bladder cancer?

BCG is administered directly into the bladder through a thin catheter. The medicine is usually retained in the bladder for a specified period before being urinated out. Treatment is generally given in a series of sessions according to the treatment plan recommended by the urologist.

How long does BCG treatment for bladder cancer take?

An individual BCG instillation is usually completed during an outpatient visit, although the exact duration can vary. BCG is commonly given as a series of treatments rather than as a single session, with the schedule determined by the treating specialist.

What should you expect before BCG treatment?

Before BCG therapy, your doctor will assess your bladder cancer, overall health and suitability for treatment. You may receive specific instructions regarding fluids, medicines and preparation before the treatment. Your healthcare team will also explain what to expect during and after each BCG instillation.

What are the common side effects of BCG treatment?

Common side effects can include frequent or uncomfortable urination, urgency, mild blood in the urine, fatigue and flu-like symptoms. More serious reactions are uncommon but can occur. Patients should contact their healthcare team if they develop severe or persistent symptoms.

How does the stage of bladder cancer affect BCG treatment outcomes?

BCG is primarily used for non-muscle-invasive bladder cancer, and outcomes can vary according to tumour stage, grade, number and size of tumours, previous recurrence and the patient’s response to treatment. Your urologist can assess these factors when discussing expected outcomes.

How does BCG treatment help prevent bladder cancer from recurring?

BCG stimulates the immune system within the bladder to target remaining abnormal cells after tumour removal. This immune response can reduce the risk of recurrence and, in appropriate patients, help lower the risk of disease progression.

What is the success rate of BCG treatment for bladder cancer?

There is no single success rate that applies to every patient. The effectiveness of BCG depends on factors such as the cancer’s stage and grade, tumour characteristics, previous treatments and response to therapy. BCG can be highly effective for appropriately selected patients with non-muscle-invasive bladder cancer, but individual outcomes vary.